These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8706074)

  • 1. [Renal involvement in monoclonal gammopathies].
    Spicka I; Merta M; Cieslar P; Stejskalová A
    Cas Lek Cesk; 1996 Jun; 135(12):374-7. PubMed ID: 8706074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal impairment in monoclonal gammapathies. Clinical study].
    Spicka I; Merta M; Cieslar P; Klener P; Chrz M; Zabka J; Mokrejsová M; Rysavá R; Slabý J; Zounar R
    Cas Lek Cesk; 1995 Aug; 134(15):478-81. PubMed ID: 7585865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ultrastructural basis of renal pathology in monoclonal gammopathies.
    Santostefano M; Zanchelli F; Zaccaria A; Poletti G; Fusaroli M
    J Nephrol; 2005; 18(6):659-75. PubMed ID: 16358223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The kidney in dysproteinemia].
    Spanti D; Marcantoni C; Di Landro D
    G Ital Nefrol; 2005; 22 Suppl 33():S39-45. PubMed ID: 16419005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kidney damage in multiple myeloma and other monoclonal gammopathies].
    Adam Z; Pour L; Krejcí M; Stĕpánková S; Svobodová I; Veselý K; Hájek R
    Vnitr Lek; 2008 Sep; 54(9):847-61. PubMed ID: 18924346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical problems in kidney disorders associated with myeloma and other paraproteinemias].
    Merta M; Spicka I; Rysavá R; Zabka J; Tesar V; Zima T; Honsová E; Stejskalová A; Vorsilková M; Walterová J
    Sb Lek; 1996; 97(4):469-77. PubMed ID: 9424712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal involvement in monoclonal gammopathy and multiple myeloma].
    De Sanctis LB; Sestigiani E; Sgarlato V; Fabbrizio B; Santoro A
    G Ital Nefrol; 2010; 27 Suppl 50():S19-33. PubMed ID: 20922692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal gammopathies of renal significance.
    Gnanasampanthan S; Kousios A
    Clin Med (Lond); 2023 May; 23(3):250-253. PubMed ID: 37236803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of nephrologist in treatment of multiple myeloma].
    Kes P; Basić-Jukić N; Jurić I; Brunetta B
    Acta Med Croatica; 2008; 62 Suppl 1():37-43. PubMed ID: 18578331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interleukin-6, tumor necrosis factor alpha and their soluble receptors in Bence-Jones nephropathy. Possible role in pathogenesis andthe importance in the determination of prognosis in renal insufficiency].
    Spicka I; Masek Z; Jirsa M; Zounar R; Procházka B; Merta M; Cieslar P; Tesar V; Klener P
    Cas Lek Cesk; 1998 May; 137(9):267-70. PubMed ID: 9650354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience.
    Stratta P; Gravellone L; Cena T; Rossi D; Gaidano G; Fenoglio R; Lazzarich E; Quaglia M; Airoldi A; Bozzola C; Monga G; Valente G; Canavese C; Magnani C
    Crit Rev Oncol Hematol; 2011 Jul; 79(1):31-42. PubMed ID: 20570173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paraproteinemia and renal diseases].
    Grandjean AP; Dettwiler S; Saudan P
    Rev Med Suisse; 2010 Mar; 6(238):460-6. PubMed ID: 20344997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Classification and therapeutic management of monoclonal gammopathies of renal significance].
    Javaugue V; Bouteau I; Sirac C; Quellard N; Diolez J; Colombo A; Desport E; Ecotière L; Goujon JM; Fermand JP; Touchard G; Jaccard A; Bridoux F
    Rev Med Interne; 2018 Mar; 39(3):161-170. PubMed ID: 28457684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selected renal complications during the course of multiple myeloma].
    Sułowicz W; Sydor A; Króliczak M; Ochmański W; Giza D; Stompór T; Wolakiewicz M; Kupaj L
    Przegl Lek; 1997; 54(12):835-40. PubMed ID: 9591450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephropathy in leptospirosis.
    Visith S; Kearkiat P
    J Postgrad Med; 2005; 51(3):184-8. PubMed ID: 16333190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal disease is a prodrome of multiple myeloma: an analysis of 50 patients from eastern India.
    Prakash J; Mandal AK; Vohra R; Wani IA; Hota JK; Raja R; Singh U
    Ren Fail; 2009; 31(4):267-71. PubMed ID: 19462274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal involvement in benign monoclonal gammopathies: an underdiagnosed condition].
    Ramos R; Poveda R; Bernís C; Ara J; Sunyer M; Arrizabalaga P; Grinyó JM
    Nefrologia; 2008; 28(5):525-9. PubMed ID: 18816211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A history of the kidney in plasma cell disorders.
    Steensma DP; Kyle RA
    Contrib Nephrol; 2007; 153():5-24. PubMed ID: 17075221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal immunoglobulin light chain-related renal diseases.
    Sanders PW; Herrera GA
    Semin Nephrol; 1993 May; 13(3):324-41. PubMed ID: 8321932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.